Ovid Therapeutics to Participate at the Stifel 2017 Healthcare Conference
NEW YORK, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company committed to developing medicines for patients with rare neurological disorders, today announced that Jeremy Levin, DPhil, MB BChir, chairman and …